2023 Q3 Form 10-Q Financial Statement

#000095017023035110 Filed on July 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $58.62M $56.06M
YoY Change 22.78% 18.0%
Cost Of Revenue $23.52M $23.00M
YoY Change 27.99% 20.99%
Gross Profit $35.10M $33.06M
YoY Change 19.52% 16.01%
Gross Profit Margin 59.87% 58.97%
Selling, General & Admin $31.53M $16.67M
YoY Change 144.64% -34.55%
% of Gross Profit 89.85% 50.42%
Research & Development $14.58M $13.32M
YoY Change 15.95% 15.27%
% of Gross Profit 41.55% 40.3%
Depreciation & Amortization $1.209M $1.353M
YoY Change 33.74% 186.05%
% of Gross Profit 3.44% 4.09%
Operating Expenses $46.12M $31.34M
YoY Change 74.88% -15.34%
Operating Profit $3.562M $1.717M
YoY Change 18.97% -43.39%
Interest Expense $0.00 $1.101M
YoY Change -100.0% 110000.0%
% of Operating Profit 0.0% 64.12%
Other Income/Expense, Net $210.0K -$159.0K
YoY Change 87.5% -174.3%
Pretax Income $4.840M $1.900M
YoY Change 41.6% -44.72%
Income Tax $295.0K $352.0K
% Of Pretax Income 6.1% 18.53%
Net Earnings $4.545M $1.089M
YoY Change 27.1% -64.17%
Net Earnings / Revenue 7.75% 1.94%
Basic Earnings Per Share $0.16 $0.04
Diluted Earnings Per Share $0.16 $0.04
COMMON SHARES
Basic Shares Outstanding 25.35M 25.34M
Diluted Shares Outstanding 26.12M 26.18M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.4M $107.1M
YoY Change 11.65% 12.85%
Cash & Equivalents $107.4M $107.1M
Short-Term Investments
Other Short-Term Assets $7.500M $6.029M
YoY Change 28.64% 35.94%
Inventory $7.485M $8.452M
Prepaid Expenses
Receivables $27.76M $27.86M
Other Receivables $0.00 $0.00
Total Short-Term Assets $153.4M $149.4M
YoY Change 12.45% 13.09%
LONG-TERM ASSETS
Property, Plant & Equipment $17.48M $40.03M
YoY Change -20.57% 578.85%
Goodwill $32.76M $33.08M
YoY Change -0.01% 0.97%
Intangibles $17.51M $17.89M
YoY Change -10.19% -9.8%
Long-Term Investments
YoY Change
Other Assets $7.816M $10.92M
YoY Change -22.5% 76.71%
Total Long-Term Assets $101.8M $101.9M
YoY Change 20.71% 33.01%
TOTAL ASSETS
Total Short-Term Assets $153.4M $149.4M
Total Long-Term Assets $101.8M $101.9M
Total Assets $255.2M $251.3M
YoY Change 15.6% 20.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.07M $10.54M
YoY Change -3.44% 28.82%
Accrued Expenses $13.76M $16.06M
YoY Change -2.13% 104.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.000K
YoY Change -100.0% -75.0%
Total Short-Term Liabilities $72.71M $73.89M
YoY Change 17.17% 17.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $4.858M $28.47M
YoY Change -69.08% 650.66%
Total Long-Term Liabilities $4.858M $28.47M
YoY Change -69.08% 650.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $72.71M $73.89M
Total Long-Term Liabilities $4.858M $28.47M
Total Liabilities $77.57M $104.7M
YoY Change -1.46% 57.22%
SHAREHOLDERS EQUITY
Retained Earnings $57.94M $53.85M
YoY Change 26.74% 26.42%
Common Stock $9.482M $9.482M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.871M $1.877M
YoY Change -4.78% -4.91%
Treasury Stock Shares
Shareholders Equity $116.6M $146.7M
YoY Change
Total Liabilities & Shareholders Equity $255.2M $251.3M
YoY Change 15.6% 20.4%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $4.545M $1.089M
YoY Change 27.1% -64.17%
Depreciation, Depletion And Amortization $1.209M $1.353M
YoY Change 33.74% 186.05%
Cash From Operating Activities $5.500M $22.00K
YoY Change 82.36% -78.22%
INVESTING ACTIVITIES
Capital Expenditures $2.900M $3.065M
YoY Change -514.88% -3227.55%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$2.000K
YoY Change -100.0% -71.43%
Cash From Investing Activities -$2.900M -$3.067M
YoY Change 317.87% 2820.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $1.000K
YoY Change 0.0%
Cash From Financing Activities -2.100M -2.702M
YoY Change 230.19% 55.38%
NET CHANGE
Cash From Operating Activities 5.500M 22.00K
Cash From Investing Activities -2.900M -3.067M
Cash From Financing Activities -2.100M -2.702M
Net Change In Cash 500.0K -5.747M
YoY Change -70.34% 177.1%
FREE CASH FLOW
Cash From Operating Activities $5.500M $22.00K
Capital Expenditures $2.900M $3.065M
Free Cash Flow $2.600M -$3.043M
YoY Change -30.01% -1629.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000078749
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
000-5734
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
AGILYSYS, INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
34-0907152
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
3655 Brookside Parkway
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Alpharetta
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30022
CY2023Q2 dei City Area Code
CityAreaCode
770
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
810-7800
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock, without par value
CY2023Q2 dei Trading Symbol
TradingSymbol
AGYS
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25353918
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107093000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112842000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
578000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
610000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25581000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22378000
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2283000
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2242000
CY2023Q2 us-gaap Inventory Net
InventoryNet
8452000
CY2023Q1 us-gaap Inventory Net
InventoryNet
9774000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6029000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7422000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
149438000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
154658000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15987000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14576000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24038000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12708000
CY2023Q2 us-gaap Goodwill
Goodwill
33077000
CY2023Q1 us-gaap Goodwill
Goodwill
32638000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17888000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18140000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2927000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2790000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7992000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7526000
CY2023Q2 us-gaap Assets
Assets
251347000
CY2023Q1 us-gaap Assets
Assets
243036000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10544000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
9418000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47291000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
52124000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11257000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13708000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4800000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3263000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1000
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
73893000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
78515000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2303000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2257000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24139000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13477000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4326000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4018000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.3
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.3
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31606831
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31606831
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25351357
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25326626
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
9482000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
9482000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6255474
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6280205
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1877000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1884000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53735000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
52978000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
53853000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
52764000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3507000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4030000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
111686000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
109310000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
251347000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
243036000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56059000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47506000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23002000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19011000
CY2023Q2 us-gaap Gross Profit
GrossProfit
33057000
CY2022Q2 us-gaap Gross Profit
GrossProfit
28495000
CY2023Q2 agys Gross Profit Ratio
GrossProfitRatio
0.59
CY2022Q2 agys Gross Profit Ratio
GrossProfitRatio
0.60
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13321000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11556000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7301000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5413000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9365000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7353000
CY2023Q2 us-gaap Depreciation
Depreciation
923000
CY2022Q2 us-gaap Depreciation
Depreciation
473000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
430000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
453000
CY2023Q2 us-gaap Other Expenses
OtherExpenses
759000
CY2022Q2 us-gaap Other Expenses
OtherExpenses
214000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32099000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25462000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
958000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3033000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1101000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
101000
CY2023Q2 us-gaap Interest Expense
InterestExpense
0
CY2022Q2 us-gaap Interest Expense
InterestExpense
-1000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
304000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1900000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3437000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
352000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
398000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1548000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3039000
CY2023Q2 agys Accretion Of Convertible Preferred Stock Dividends
AccretionOfConvertiblePreferredStockDividends
-459000
CY2022Q2 agys Accretion Of Convertible Preferred Stock Dividends
AccretionOfConvertiblePreferredStockDividends
-459000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1089000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2580000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24936000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24598000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26177000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25370000
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1548000
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3039000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
523000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-398000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2071000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2641000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1548000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3039000
CY2023Q2 us-gaap Depreciation
Depreciation
923000
CY2022Q2 us-gaap Depreciation
Depreciation
473000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
430000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
453000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-129000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-116000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3167000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2488000
CY2023Q2 agys Increase Decrease In Operating Assets And Liabilties
IncreaseDecreaseInOperatingAssetsAndLiabilties
5917000
CY2022Q2 agys Increase Decrease In Operating Assets And Liabilties
IncreaseDecreaseInOperatingAssetsAndLiabilties
6236000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
101000
CY2023Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3065000
CY2022Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
98000
CY2023Q2 us-gaap Payments For Proceeds From Life Insurance Policies
PaymentsForProceedsFromLifeInsurancePolicies
2000
CY2022Q2 us-gaap Payments For Proceeds From Life Insurance Policies
PaymentsForProceedsFromLifeInsurancePolicies
7000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3067000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-105000
CY2023Q2 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
918000
CY2022Q2 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
918000
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1783000
CY2022Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
820000
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000
CY2022Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2702000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1739000
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-331000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5749000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2074000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112842000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96971000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107093000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94897000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
109310000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3377000
CY2023Q2 agys Repurchases Of Shares To Satisfy Employee Tax Withholding
RepurchasesOfSharesToSatisfyEmployeeTaxWithholding
-2613000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1548000
CY2023Q2 agys Accretion Of Convertible Preferred Stock Dividends
AccretionOfConvertiblePreferredStockDividends
-459000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
523000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
111686000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
97344000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2623000
CY2022Q2 agys Repurchases Of Shares To Satisfy Employee Tax Withholding
RepurchasesOfSharesToSatisfyEmployeeTaxWithholding
-873000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3039000
CY2022Q2 agys Accretion Of Convertible Preferred Stock Dividends
AccretionOfConvertiblePreferredStockDividends
-459000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-398000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
101276000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
22100000
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
20900000
CY2023Q2 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
1600000
CY2022Q2 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
1500000
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
4000000
CY2022Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3300000
CY2023Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
900000
CY2022Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
700000
CY2023Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
400000
CY2022Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
300000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7946000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11170000
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
2602000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
2127000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
105000
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
95000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
604000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
316000
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
11257000
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
13708000
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1184000
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1178000
CY2023Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
3041000
CY2023Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
2742000
CY2023Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
101000
CY2023Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
98000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4326000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4018000
CY2023Q2 agys Number Of Operating Leases
NumberOfOperatingLeases
2
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12400000
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y4M24D
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1548000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3039000
CY2023Q2 agys Accretion Of Convertible Preferred Stock Dividends
AccretionOfConvertiblePreferredStockDividends
-459000
CY2022Q2 agys Accretion Of Convertible Preferred Stock Dividends
AccretionOfConvertiblePreferredStockDividends
-459000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1089000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2580000
CY2023Q2 agys Interest Paid Receipts
InterestPaidReceipts
893000
CY2022Q2 agys Interest Paid Receipts
InterestPaidReceipts
100000
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
376000
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
332000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1425000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1468000
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000
CY2022Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
320000
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
158000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
352000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
398000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.185
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.116
CY2023Q2 agys Regular Corporate Income Tax Rate India
RegularCorporateIncomeTaxRateIndia
0.50
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24936000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24598000
CY2023Q2 agys Dilutive Ssa Rs
DilutiveSSARs
1008000
CY2022Q2 agys Dilutive Ssa Rs
DilutiveSSARs
728000
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
231000
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
44000
CY2023Q2 agys Dilutive Unvested Restricted Stock Units
DilutiveUnvestedRestrictedStockUnits
2000
CY2022Q2 agys Dilutive Unvested Restricted Stock Units
DilutiveUnvestedRestrictedStockUnits
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26177000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25370000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1735000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1797000
CY2023Q2 agys Incremental Common Shares Attributable To Restricted Shares
IncrementalCommonSharesAttributableToRestrictedShares
339956000
CY2022Q2 agys Incremental Common Shares Attributable To Restricted Shares
IncrementalCommonSharesAttributableToRestrictedShares
390361000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3167000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2488000
CY2023Q2 us-gaap Debt Instrument Convertible Earliest Date1
DebtInstrumentConvertibleEarliestDate1
2023-11-22
CY2023Q2 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
1.50
CY2023Q2 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
20
us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
30
CY2023Q2 us-gaap Dividend Payment Restrictions Schedule Description
DividendPaymentRestrictionsScheduleDescription
The Holders are entitled to dividends on the Liquidation Preference at the rate of 5.25% per annum, payable semi-annually either (i) 50% in cash and 50% in kind as an increase in the then-current Liquidation Preference or (ii) 100% in cash, at the option of the Company.
CY2023Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.0525

Files In Submission

Name View Source Status
0000950170-23-035110-index-headers.html Edgar Link pending
0000950170-23-035110-index.html Edgar Link pending
0000950170-23-035110.txt Edgar Link pending
0000950170-23-035110-xbrl.zip Edgar Link pending
agys-20230630.htm Edgar Link pending
agys-20230630.xsd Edgar Link pending
agys-20230630_cal.xml Edgar Link unprocessable
agys-ex31_1.htm Edgar Link pending
agys-ex31_2.htm Edgar Link pending
agys-ex31_3.htm Edgar Link pending
agys-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
agys-20230630_lab.xml Edgar Link unprocessable
agys-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
agys-20230630_htm.xml Edgar Link completed
agys-20230630_def.xml Edgar Link unprocessable